Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Recent advances in the management of hepatocellular carcinoma

Kamya Sankar, Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen, Andrew E. Hendifar, Ekaterina K. Koltsova, Ju Dong Yang

Clin Mol Hepatol. 2024;30(1):1-15. Published online July 21, 2023

DOI: https://doi.org/10.3350/cmh.2023.0125

View: 5396 Download: 277 Web of Science: 3 Crossref: 4

Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management

Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra

Clin Mol Hepatol. 2023;29(Suppl):S286-S301. Published online December 28, 2022

DOI: https://doi.org/10.3350/cmh.2022.0392

View: 5235 Download: 245 Web of Science: 10 Crossref: 11

Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease

Peter Konyn, Aijaz Ahmed, Donghee Kim

Clin Mol Hepatol. 2023;29(Suppl):S43-S57. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0351

View: 3681 Download: 157 Web of Science: 16 Crossref: 14

Correspondence

Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”

Joo Hyun Oh, Dong Hyun Sinn

Clin Mol Hepatol. 2023;29(3):820-820. Published online May 19, 2023

DOI: https://doi.org/10.3350/cmh.2023.0135

View: 1590 Download: 27

Editorial

Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed

Philipp Kasper, Münevver Demir, Hans-Michael Steffen

Clin Mol Hepatol. 2023;29(2):390-393. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0059

View: 2406 Download: 54 Web of Science: 2 Crossref: 2

Review

Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review

Lei Miao, Jing Xu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng

Clin Mol Hepatol. 2022;28(4):725-738. Published online March 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0015

View: 4675 Download: 245 Web of Science: 7 Crossref: 10

Current knowledge about biomarkers of acute kidney injury in liver cirrhosis

Han Ah Lee, Yeon Seok Seo

Clin Mol Hepatol. 2022;28(1):31-46. Published online August 2, 2021

DOI: https://doi.org/10.3350/cmh.2021.0148

View: 6378 Download: 316 Web of Science: 11 Crossref: 12

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Oxidative stress and glutamate excretion in alcoholic steatosis: Metabolic synapse between hepatocyte and stellate cell

Hee-Hoon Kim, Sung Eun Choi, Won-Il Jeong

Clin Mol Hepatol. 2020;26(4):697-704. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0152

View: 5998 Download: 143 Web of Science: 9 Crossref: 7

Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake

Seonghwan Hwang, Tianyi Ren, Bin Gao

Clin Mol Hepatol. 2020;26(4):586-594. Published online September 17, 2020

DOI: https://doi.org/10.3350/cmh.2020.0100

View: 7156 Download: 204 Web of Science: 17 Crossref: 17

Original Article

Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway

Seulki Lee, Eun Ji Choi, Eun Ju Cho, Yun Bin Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2020;26(4):529-539. Published online August 24, 2020

DOI: https://doi.org/10.3350/cmh.2019.0056n

View: 7774 Download: 241 Web of Science: 30 Crossref: 29

Editorial

Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma

Jaewhan Song

Clin Mol Hepatol. 2020;26(4):484-486. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0220

View: 5767 Download: 133 Web of Science: 7 Crossref: 7

Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma

Sojung Han, Do Young Kim

Clin Mol Hepatol. 2020;26(3):305-308. Published online July 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0096

View: 4197 Download: 108 Web of Science: 5 Crossref: 5

Review

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs

Stephen Caldwell

Clin Mol Hepatol. 2017;23(2):103-108. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0103

View: 12079 Download: 473 Web of Science: 30 Crossref: 31

Genetic predisposition in nonalcoholic fatty liver disease

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2017;23(1):1-12. Published online March 9, 2017

DOI: https://doi.org/10.3350/cmh.2016.0109

View: 17758 Download: 604 Web of Science: 145 Crossref: 145

Original Article

Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma

Jee Eun Yang, Eunji Park, Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eunsil Yu, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2014;20(1):28-37. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.28

View: 7723 Download: 63 Web of Science: 2 Crossref: 2

Case Report

Three cases of glycogenic hepatopathy mimicking acute and relapsing hepatitis in type I diabetes mellitus

Jae Hwang Cha, Sang Ho Ra, Yu Mi Park, Yong Kwan Ji, Ji Hyun Lee, So Yeon Park, Soon Koo Baik, Sang Ok Kwon, Mee Yon Cho, Moon Young Kim

Clin Mol Hepatol. 2013;19(4):421-425. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.421

View: 7614 Download: 77 Crossref: 22

Original Article

Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma

Soon Ha Kwon, Soung Won Jeong, Jae Young Jang, Ji Eun Lee, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, So-Young Jin

Clin Mol Hepatol. 2012;18(3):287-294. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.287

View: 7499 Download: 84 Crossref: 12

Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH

Min Yong Yoon, Jun Mo Sung, Chang Seok Song, Won Young Lee, Eun Jung Rhee, Jun Ho Shin, Chang Hak Yoo, Seoung Wan Chae, Ja Yeon Kim, Wook Jin, Yong Kyun Cho

Clin Mol Hepatol. 2012;18(3):279-286. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.279

View: 6783 Download: 71 Crossref: 11

Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients

Yun Jung Kim, Byoung Kuk Jang, Eun Soo Kim, Kyung Sik Park, Kwang Bum Cho, Woo Jin Chung, Jae Seok Hwang

Clin Mol Hepatol. 2012;18(1):41-47. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.41

View: 7637 Download: 38 Crossref: 10

3

Validity and reliability of the nonalcoholic fatty Liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors

Kyung-Hun Lee, M.D., Sang Hoon Park, M.D., Yu Jin Kim, M.D., Kyung Rim Huh, M.D., Kwang Seon Min M.D., Sun-Young Jun M.D., Kyoung Oh Kim, M.D., Cheol Hee Park, M.D., Taeho Hahn, M.D., Kyo-Sang Yoo, M.D., Jong Hyeok Kim, M.D., Myung-Seok Lee, M.D., Choong Kee Park, M.D.

Clin Mol Hepatol. 2010;16(1):29-37. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.29

View: 5064 Download: 52 Crossref: 2

7

The Korean Journal of Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma

Jeong Heo

Clin Mol Hepatol. 2009;15(2):227-230. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.227

View: 3905 Download: 26 Crossref: 1

3

Inhibition of in vitro hepatitis B virus replication by Lentivirus-mediated short-hairpin RNA against HBx

Jin Wook Kim , Sang Hyub Lee , Young Soo Park , Sook Hyang Jeong , Na Young Kim , Dong Ho Lee

Clin Mol Hepatol. 2009;15(1):15-24. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.15

View: 4935 Download: 57 Crossref: 6

Down-regulation of survivin in growth inhibition of hepatoma cells induced by a selective cyclooxygenase-2 inhibitor

Il Han Song, M.D., Dong Woo Kim, M.D., Ki Chul Shin, M.D., Hyun Duk Shin, M.D., Se Young Yun, M.D., Suk Bae Kim, M.D., Jung Eun Shin, M.D., Hong Ja Kim, M.D., Eun Young Kim, M.D.

Clin Mol Hepatol. 2008;14(3):351-359. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.351

View: 4035 Download: 24 Crossref: 4

1

Anti-tumor mechanisms and regulation of survivin by selective cyclooxygenase-2 inhibitor

Jeong Won Jang

Clin Mol Hepatol. 2008;14(3):305-308. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.305

View: 3836 Download: 19 Crossref: 4

2

Nonalcoholic steatohepatitis: Pathogenesis and treatment

Sang Hoon Park

Clin Mol Hepatol. 2008;14(1):12-27. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.12

View: 6897 Download: 105 Crossref: 5

7

The Korean Journal of The Efficacy of Sorafenib for Patients With Advanced Hepatocellular Carcinoma

Jeong Heo

Clin Mol Hepatol. 2007;13(4):576-580. Published online December 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.4.576

View: 3151 Download: 15

3

Expression of G1 Cell Cycle Regulators in Rat Liver upon Repeated Exposure to Thioacetamide

Kyoung-Tae Kim, M.D., Sang-Young Han, M.D., Ph.D., Jin-Sook Jeong, M.D., Ph.D.

Clin Mol Hepatol. 2007;13(1):81-90. Published online January 1, 1970

View: 2439 Download: 18

5

Nonalcoholic Steatohepatitis

So-Young Jin

Clin Mol Hepatol. 2006;12(3):455-459. Published online January 1, 2000

View: 2567 Download: 20

4

Extrahepatic Metastasis of Hepatocellular Carcinoma to the Nasal Cavity Manifested as Massive Epistaxis: A Case Report

Sung Jae Yoo, M.D., Jae Hee Cheon, M.D., Sang Won Lee, M.D., Yoo Seok Jung, M.D. , Sang Hyun Lee, M.D., Joong-Won Park, M.D.*, Eun Kyoung Hong, M.D.* and Chang-Min Kim, M.D.*

Clin Mol Hepatol. 2004;10(3):228-232. Published online January 1, 1970

View: 2552 Download: 25

3

The Prevalence of Metabolic Syndrome in Patients with Nonalcoholic Fatty Liver Disease

Ki Won Moon, M.D., Joung Muk Leem, M.D., Sang Seok Bae, M.D., Ki Man Lee, M.D., Seok Hyung Kim, M.D.*, Hee Bok Chae, M.D., Seon Mee Park, M.D. and Sei Jin Youn, M.D.

Clin Mol Hepatol. 2004;10(3):197-206. Published online January 1, 1970

View: 3103 Download: 58

1 | 2 |

Viewed By 5627	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4848	MAFLD: How is it different from NAFLD?
Viewed By 4604	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3746	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3735	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search